MECP2 and breast carcinoma: And in ER‐negative MDA‐MB‐231 cells, which are more malignant, displayed higher expression of MECP2, suggesting the association between prominent epigenetic alterations and increased malignant properties of breast cancer cells (Tryndyak et al., 2006).